DexCom recently announced that the U.S. Food and Drug Administration’s (FDA) Clinical Chemistry and Clinical Toxicology Devices Panel has voted to approve the DexCom G5 Mobile CGM system’s proposed non-adjunctive indication. Read More »
Two high-cost arthritis medications — one the world’s best-selling drug — may soon make way for generic equivalents following preliminary committee approval, but the Food and Drug Administration must still decide whether the products are fully interchangeable. Read More »
.jpg)
Spark Therapeutics and Pfizer Inc. recently announced that SPK-9001 has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA). Read More »
Cigna has responded to the U.S. Department of Justice’s (DOJ) decision to challenge its merger with Anthem. Read More »
Ajanta Pharma USA Inc., an Ajanta Pharm Ltd subsidiary, recently announced that it has launched the generic form of Zegerid Capsules, called Omeprazole and Sodium Bicarbonate Capsules, in the United State Read More »
Ionis Pharmaceuticals, Inc. recently announced $10 million in earnings from Janssen Biotech Inc. after licensing the drug, INOIS-JBI1-2.5Rx, which is designed to hinder an undisclosed target in the gastrointestinal (GI) tract that is used to treat GI autoimmune disease. Read More »
Lannett Company, Inc. recently announced that an Acceptable for Filing letter has been issued to its strategic partner Sparsha Pharma USA, Inc. from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fentanyl Transdermal System. Read More »
Encouraging test results in bioavailability of therapeutically equivalent dose used for COPD treatment. Read More »
Allergan recently announced that it has surpassed its goal of donating $1 million worth of REFRESH eye drops to first responders around the country. Read More »
Extended-release Belviq XR tablets approved for use with low-calorie diet and exercise plan. Read More »
Namzaric approved as a combination therapy for moderate to severe Alzheimer's patients. Read More »
The World Health Organization (WHO) this week prequalified the four-dose, multi-dose vial (MDV) for Pfizer Inc.’s Prevenar 13. Read More »
The National Association of Chain Drug Stores (NACDS) recently announced a nationwide tour to promote the Test2Learn Community-Based Pharmacogenomics Certificate Program this fall with its partner, the University of Pittsburgh School of Pharmacy. Read More »
FDA approves Differin Gel as an over-the-counter medication; prescription no longer needed. Read More »
An advisory panel of the Federal Drug Administration (FDA) recently recommended approval of a medication manufactured by Amgen as a feasible alternative product to Humira, a brand created by AbbVie. Read More »
The fifth edition of the leading pharmaceutical compounding textbook was released last week. Read More »
TPP program rigorously evaluated teen prevention programs for effectiveness. Read More »
Virginia Cancer Specialists (VCA) has enrolled its first patient in its upcoming advanced lung cancer clinical trial, making it the first center in the world to do so. Read More »
Pfizer announces positive results from year-long S-TRAC trial of SUTENT. Read More »
Bexion Pharmaceuticals, LLC today announced that its application to begin a First-in-Human Phase 1 clinical trial with BXQ-350 has been accepted by the U..S Food and Drug Administration (FDA). Read More »
Alerts Sign-up
